Cancer Traetment

tolera

Tolera Therapeutics Closes Series B-3 Financing, Raises $5.5M

Tolera Therapeutics Inc., a privately held biotechnology company focusing on the development of immunotherapeutics directed at the transplantation, autoimmune and oncology markets, announced today that it has closed its Series B-3 financing.

WWJ Newsradio 950–10/16/2012

Follow

Get every new post delivered to your Inbox.

Join 1,935 other followers